“None of the available evidence for Nevirapine comes from a trial in which it was tested against a placebo. Yet, as the study’s senior author has said, a placebo is the only way a scientist can assess a drug’s effectiveness with scientific certainty.”58 Dr. Turner observed that the transmission rate that HIVNET 012 reported for HIV—13.1 percent—was above the background transmission rate. “The HIVNET 012 outcome is higher than the 12 percent transmission rate reported in a prospective study of 561 African women given no antiretroviral treatment. This, in effect, is the placebo group.” If
...more

